Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NYSE:G

Genpact Ltd (G)

31.02
-1.04 (3.24%)
as of Jun 15, 2026, 7:31:00 pm Market Open.
1 watching
0
Investor Insights
star iconJun 15, 2026, 12:00 am

This summary was created by AI, based on 3 opinions in the last 12 months.

Genpact Ltd (G-N) has garnered mixed reviews from experts, emphasizing its strong historical performance and growth potential in banking and insurance services. This company has achieved an impressive 13% earnings growth over 15 years, currently trading at a PE ratio of 9.7x and a free cash flow yield of 8.5%. Despite recent challenges, including a 20% decline this year due to fears surrounding AI, these concerns are viewed as unfounded by at least one expert. However, other analysts have recommended adjusting stop losses to remain disciplined and cautious, indicating a level of stagnation in stock performance. Overall, while the company's fundamentals seem strong, the current market sentiment appears to warrant a more conservative approach.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Undervalued
review icon
Similar
DigiN, D-N
BUY ON WEAKNESS
Might be a little high. Perfers in the low $20's.
PAST TOP PICK
(Was a top pick on April 10 up 7.5%) A little expensive now but they are still holding.
DON'T BUY
Will be hard to have more growth.
TOP PICK
A leader in all its products. Strong mngmnt.
DON'T BUY
Dominant in razor blades. Not a fan of mngmnt (old thinking?). Concerns on their business model. A one product company.
DON'T BUY
Management has stumbled.
Showing 16 to 21 of 21 entries